{"pmid":32399903,"title":"[The \"Historic Study\" SOLIDARITY-Research's Answer to the Sars-CoV-2 Pandemic].","text":["[The \"Historic Study\" SOLIDARITY-Research's Answer to the Sars-CoV-2 Pandemic].","This paper is part of Forum COVID-19: Perspectives in the Humanities and Social Sciences. The novel coronavirus (Sars-CoV-2) poses a huge challenge to the world community. Knowledge about the virus and its properties is limited, but there is a great need to base political and medical decisions on scientific knowledge. This situation is leading to a dynamization of research. A prominent example of such a development is SOLIDARITY. The epistemological dimensions of this trial, which is coordinated by the WHO, and the resulting ethical implications are discussed in this article.","NTM","Gadebusch Bondio, Mariacarla","Marloth, Maria","32399903"],"abstract":["This paper is part of Forum COVID-19: Perspectives in the Humanities and Social Sciences. The novel coronavirus (Sars-CoV-2) poses a huge challenge to the world community. Knowledge about the virus and its properties is limited, but there is a great need to base political and medical decisions on scientific knowledge. This situation is leading to a dynamization of research. A prominent example of such a development is SOLIDARITY. The epistemological dimensions of this trial, which is coordinated by the WHO, and the resulting ethical implications are discussed in this article."],"journal":"NTM","authors":["Gadebusch Bondio, Mariacarla","Marloth, Maria"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399903","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s00048-020-00257-5","keywords":["covid-19","evidence-based medicine","research ethics","solidarity","who"],"weight":0,"_version_":1666865855086985218,"score":9.490897,"similar":[{"pmid":32382898,"pmcid":"PMC7203719","title":"[COVID-19, and the History of Social Science Disaster Research].","text":["[COVID-19, and the History of Social Science Disaster Research].","This paper is part of Forum COVID-19: Perspectives in the Humanities and Social Sciences.The article connects and juxtaposes current day (social scientific) discussions on the social effects of the COVID-crisis with the history of social science disaster research during the Cold War. It elaborates on statements regarding the role of social inequalities in disaster, the idea of the \"revealing\" nature of disaster and crisis, and the relationship between disaster science, public and politics.","NTM","Stehrenberger, Cecile Stephanie","32382898"],"abstract":["This paper is part of Forum COVID-19: Perspectives in the Humanities and Social Sciences.The article connects and juxtaposes current day (social scientific) discussions on the social effects of the COVID-crisis with the history of social science disaster research during the Cold War. It elaborates on statements regarding the role of social inequalities in disaster, the idea of the \"revealing\" nature of disaster and crisis, and the relationship between disaster science, public and politics."],"journal":"NTM","authors":["Stehrenberger, Cecile Stephanie"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32382898","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1007/s00048-020-00254-8","keywords":["covid-19","disaster","disaster research","social sciences"],"weight":0,"_version_":1666419683305193472,"score":173.40369},{"pmid":32399902,"title":"[Pandemic and Epidemic History as Nursing History?]","text":["[Pandemic and Epidemic History as Nursing History?]","This paper is part of Forum COVID-19: Perspectives in the Humanities and Social Sciences. In the current COVID 19 pandemic, the importance of professional nursing is widely recognized. In German-speaking and international research, the history of nursing during pandemics and epidemics is largely unwritten. This paper gives an overview of questions and results in this research area and discusses the potential of a pandemic nursing history.","NTM","Nolte, Karen","32399902"],"abstract":["This paper is part of Forum COVID-19: Perspectives in the Humanities and Social Sciences. In the current COVID 19 pandemic, the importance of professional nursing is widely recognized. In German-speaking and international research, the history of nursing during pandemics and epidemics is largely unwritten. This paper gives an overview of questions and results in this research area and discusses the potential of a pandemic nursing history."],"journal":"NTM","authors":["Nolte, Karen"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399902","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s00048-020-00252-w","keywords":["covid-19","historiography","nursing","nursing history","pandemics"],"topics":["Prevention"],"weight":1,"_version_":1666714494902992896,"score":124.08187},{"pmid":32461245,"title":"Ethical guidelines for deliberately infecting volunteers with COVID-19.","text":["Ethical guidelines for deliberately infecting volunteers with COVID-19.","Global fatalities related to COVID-19 are expected to be high in 2020-2021. Developing and delivering a vaccine may be the most likely way to end the pandemic. If it were possible to shorten this development time by weeks or months, this may have a significant effect on reducing deaths. Phase II and phase III trials could take less long to conduct if they used human challenge methods-that is, deliberately infecting participants with COVID-19 following inoculation. This article analyses arguments for and against such methods and provides suggested broad guidelines for regulators, researchers and ethics committees when considering these matters. It concludes that it may be possible to maintain current ethical standards yet still permit human challenge trials in a context where delay is critical. The implications are that regulators and researchers need to work together now to design robust but short trials and streamline ethics approval processes so that they are in place when applications for trials are made.","J Med Ethics","Richards, Adair D","32461245"],"abstract":["Global fatalities related to COVID-19 are expected to be high in 2020-2021. Developing and delivering a vaccine may be the most likely way to end the pandemic. If it were possible to shorten this development time by weeks or months, this may have a significant effect on reducing deaths. Phase II and phase III trials could take less long to conduct if they used human challenge methods-that is, deliberately infecting participants with COVID-19 following inoculation. This article analyses arguments for and against such methods and provides suggested broad guidelines for regulators, researchers and ethics committees when considering these matters. It concludes that it may be possible to maintain current ethical standards yet still permit human challenge trials in a context where delay is critical. The implications are that regulators and researchers need to work together now to design robust but short trials and streamline ethics approval processes so that they are in place when applications for trials are made."],"journal":"J Med Ethics","authors":["Richards, Adair D"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32461245","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1136/medethics-2020-106322","keywords":["ethics committees/consultation","informed consent","policy guidelines/inst","public policy","research ethics","review boards/review cttes"],"weight":0,"_version_":1668079521316732928,"score":115.94108},{"pmid":32410347,"title":"Equitably Sharing the Benefits and Burdens of Research: Covid-19 Raises the Stakes.","text":["Equitably Sharing the Benefits and Burdens of Research: Covid-19 Raises the Stakes.","One of the central principles of research ethics is that the benefits and burdens of research with human participants should be equitably distributed. This principle has important implications for where research will be conducted, how participants will be recruited, what questions will be investigated, and who will control the distribution of any innovations that result. In the context of Covid-19, key issues include providing support to clinical trials in low- and middle-income countries, without taking needed resources away from other critical clinical and public health needs; designing recruitment strategies likely to generate sufficient enrollment from groups that have been disproportionately burdened by the virus, such as African Americans; supporting studies designed to improve outcomes in high-risk environments, such as nursing homes and group homes for the developmentally disabled; and ensuring that the medical products resulting from research are made available throughout the world at an affordable price. If clinical trials are not designed with equity considerations consciously in mind, the response to the pandemic may further exacerbate disparities in health status between population groups.","Ethics Hum Res","Coleman, Carl H","32410347"],"abstract":["One of the central principles of research ethics is that the benefits and burdens of research with human participants should be equitably distributed. This principle has important implications for where research will be conducted, how participants will be recruited, what questions will be investigated, and who will control the distribution of any innovations that result. In the context of Covid-19, key issues include providing support to clinical trials in low- and middle-income countries, without taking needed resources away from other critical clinical and public health needs; designing recruitment strategies likely to generate sufficient enrollment from groups that have been disproportionately burdened by the virus, such as African Americans; supporting studies designed to improve outcomes in high-risk environments, such as nursing homes and group homes for the developmentally disabled; and ensuring that the medical products resulting from research are made available throughout the world at an affordable price. If clinical trials are not designed with equity considerations consciously in mind, the response to the pandemic may further exacerbate disparities in health status between population groups."],"journal":"Ethics Hum Res","authors":["Coleman, Carl H"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32410347","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/eahr.500055","keywords":["covid-19","lmic countries","benefits and burdens of research","clinical trials","equity in clinical research","health disparities","research ethics"],"locations":["African Americans"],"countries":["United States"],"countries_codes":["USA|United States"],"weight":0,"_version_":1666897319197409280,"score":115.10913},{"pmid":32478398,"title":"Successful smallpox eradication: what can we learn to control COVID-19?","text":["Successful smallpox eradication: what can we learn to control COVID-19?","J Travel Med","Heymann, D L","Wilder-Smith, Annelies","32478398"],"journal":"J Travel Med","authors":["Heymann, D L","Wilder-Smith, Annelies"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478398","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1093/jtm/taaa090","keywords":["act accelerator","dr tedros","sars-cov-2","who","global coordination","pandemic","public health emergency of international concern","solidarity"],"topics":["Prevention"],"weight":1,"_version_":1668532089503350784,"score":114.23496}]}